Founded with the mission to innovate respiratory care, Liberate Medical focuses on non-invasive respiratory muscle stimulation technologies. Their core product, VentFree, is designed to contract expiratory muscles during mechanical ventilation, potentially reducing muscle atrophy and the duration of mechanical ventilation. This technology is synchronized with a patient's breathing cycle, addressing a critical need in the care of mechanically ventilated patients who are at risk of respiratory muscle failure.
Liberate Medical has garnered attention from notable investors and medical professionals who recognize the potential impact of their technology. The company's achievements include successful clinical trials and regulatory approvals that validate the efficacy of VentFree. By improving patient outcomes and reducing healthcare costs, Liberate Medical is making significant strides in the field of respiratory care, positioning itself as a leader in innovative medical solutions.
